Lamotrigine May Increase Risk for Heart Arrhythmias, FDA Warns
5 Apr, 2021 | 01:12h | UTCLamotrigine May Increase Risk for Heart Arrhythmias, FDA Warns – NEJM Journal Watch
FDA Safety Communication: Lamictal (lamotrigine): Drug Safety Communication – Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease
Related commentary: Epileptologists Push Back on FDA’s New Cardiac Warning for Lamotrigine – Neurology Today